These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26169344)

  • 1. VDR gene polymorphisms are associated with the clinical response to calcipotriol in psoriatic patients.
    Zhao Y; Chen X; Li J; He Y; Su J; Chen M; Zhang W; Chen W; Zhu W
    J Dermatol Sci; 2015 Sep; 79(3):305-7. PubMed ID: 26169344
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D receptor gene polymorphisms are associated with psoriasis susceptibility and the clinical response to calcipotriol in psoriatic patients.
    Liu J; Wang W; Liu K; Wan D; Wu Z; Cao Z; Luo Y; Xiao C; Yin M
    Exp Dermatol; 2020 Dec; 29(12):1186-1190. PubMed ID: 32997398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis.
    van de Kerkhof PC; Cambazard F; Hutchinson PE; Haneke E; Wong E; Souteyrand P; Damstra RJ; Combemale P; Neumann MH; Chalmers RJ; Olsen L; Revuz J
    Br J Dermatol; 1998 Jan; 138(1):84-9. PubMed ID: 9536227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor polymorphism and calcipotriol response in patients with psoriasis.
    Mee JB; Cork MJ
    J Invest Dermatol; 1998 Mar; 110(3):301-2. PubMed ID: 9506454
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitamin D and systemic therapy.
    van de Kerkhof P
    Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor genotypes are not associated with clinical response to calcipotriol in Korean psoriasis patients.
    Lee DY; Park BS; Choi KH; Jeon JH; Cho KH; Song KY; Kim IG; Youn JI
    Arch Dermatol Res; 2002 Mar; 294(1-2):1-5. PubMed ID: 12071154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in psoriasis therapy.
    Koo J; Nguyen Q; Gambla C
    Adv Dermatol; 1997; 12():47-72; discussion 73. PubMed ID: 8973735
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination of acitretin and oral calcitriol for treatment of plaque-type psoriasis.
    Ezquerra GM; Regaña MS; Millet PU
    Acta Derm Venereol; 2007; 87(5):449-50. PubMed ID: 17721663
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol.
    Kontula K; Välimäki S; Kainulainen K; Viitanen AM; Keski-Oja J
    Br J Dermatol; 1997 Jun; 136(6):977-8. PubMed ID: 9217847
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psoriasis].
    Guilhou JJ; Girard C
    Rev Prat; 2006 Dec; 56(19):2153-8. PubMed ID: 17416055
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
    Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
    Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis.
    Halsall JA; Osborne JE; Pringle JH; Hutchinson PE
    Pharmacogenet Genomics; 2005 May; 15(5):349-55. PubMed ID: 15864137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grover's disease: successful treatment with acitretin and calcipotriol.
    Miljković J; Marko PB
    Wien Klin Wochenschr; 2004; 116 Suppl 2():81-3. PubMed ID: 15506319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in facial discoid dermatosis with calcipotriol/betamethasone ointment and low-dose acitretin.
    Bohdanowicz M; DeKoven JG
    Clin Exp Dermatol; 2018 Oct; 43(7):820-821. PubMed ID: 29770475
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
    Giannetti A; Coppini M; Bertazzoni MG; Califano A; Altieri E; Pazzaglia A; Lega M; Lombardo M; Pelfini C; Veller Fornasa C; Rabbiosi G; Cespa M
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):91-5. PubMed ID: 10568486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis.
    Tzung TY; Chen CY; Yang CY; Lo PY; Chen YH
    Acta Derm Venereol; 2008; 88(3):279-80. PubMed ID: 18480933
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M; Mrowietz U; Koenig M; Simon JC
    Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrodermatitis continua of Hallopeau: response to combined treatment with acitretin and calcipotriol ointment.
    Kuijpers AL; van Dooren-Greebe RJ; van de Kerkhof PC
    Dermatology; 1996; 192(4):357-9. PubMed ID: 8864375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study.
    Vena GA; Galluccio A; Pezza M; Vestita M; Cassano N
    J Dermatolog Treat; 2012 Aug; 23(4):255-60. PubMed ID: 21756153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.